Ross Klosterman, MPH
Columbus, Ohio, United States
2K followers
500+ connections
About
Doing what I can to meaningfully change the healthcare industry for the better…
Experience
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Education
-
-
-
-
-
-
-
Licenses & Certifications
-
-
Certified Public Accountant
Commonwealth of Massachusetts Division of Professional Licensure
IssuedCredential ID 30,240
Volunteer Experience
-
-
Board Member; Treasurer
The Marble Collection, Inc. [TMC]
- 3 years
Arts and Culture
-
-
LINC Council Executive Committee Member
United Way of Massachusetts Bay and Merrimack Valley
- 2 years 2 months
Children
Publications
-
Understanding the Behavioral Health Landscape of 2016
Provident Healthcare Partners
See publicationProvident Perspectives– The behavioral health sector has experienced unprecedented growth over the past ten years. In this Provident Perspective, we cover two subsectors that have been the source of a great deal of investor interest, and that we believe will continue to be the focus of both strategic and financial sponsors over the coming years.
-
GoPro Or Go Home: Can This Company Sustain Current Valuation?
Seeking Alpha
See publication- Initiating coverage on GoPro Inc. with a SELL rating and $60 Price Target.
- Based on optimistic camera and media revenue, the company is still quite overvalued.
- GoPro as a media company will have to compete with the likes of Red Bull Media House and ESPN. -
La Jolla Pharmaceuticals And The Aftermath Of The Phase II Data Readout
Seeking Alpha
See publication- La Jolla has had many positive developments since the beginning of the year, including uplisting and an expanded drug pipeline.
- Key data from the GCS-100 Phase II trial was revealed at the Roth Investor Conference, and results were mixed.
- A unique analysis versus what has been opined to date perhaps provides some silver lining to otherwise questionable data. -
La Jolla Pharmaceutical - Can This Micro-Cap Company Make It In The Big Leagues?
Seeking Alpha
See publication- Initiating La Jolla (LJPC) with a BUY and $14 price target on positive developments and new management
Other similar profiles
Explore more posts
-
SC Moatti
I’m excited to share that Angle Health, founded by former Palantir Technologies execs Tylon (Ty) W. and Anirban Gangopadhyay, has announced an oversubscribed Series B bringing total funding to nearly $200M. I’m proud to be an early investor and to have led this competitive round with the amazing team at Portage. Why we keep leaning in: - 26x revenue growth since the Series A - Serving 3,000+ employers across 44 states - 80%+ renewal rates Angle Health is rebuilding the healthcare benefits infrastructure for SMBs, who employ nearly half of America’s workforce but have historically been shut out of enterprise-grade coverage. Their AI-native platform helps predict risk and deliver better care at a sustainable cost. This is exactly the kind of product-driven, AI-native company we’re proud to support at Mighty Capital.
-
Eric Berry
Great HLTH 2025. Some big trends I saw: - Drug distribution is going direct - Payers want vendors to take risk - Everyone has a chatbot - Behavioral health is maturing - FDA clearance is the new Series B - Post-discharge is a big opportunity - Diagnostics are becoming portable and ROI-oriented - Provider workflows are becoming consumer-grade
4 Comments -
Jonathan Friedman
Too many startups assume: 𝙩𝙝𝙚𝙧𝙚’𝙨 𝙖 𝘾𝙋𝙏 𝙘𝙤𝙙𝙚 → 𝙩𝙝𝙚𝙧𝙚𝙛𝙤𝙧𝙚 𝙩𝙝𝙚𝙧𝙚’𝙨 𝙖 𝙗𝙪𝙨𝙞𝙣𝙚𝙨𝙨. Reality is rarely that linear. Viability tends to unfold in fits and starts, shaped by payer coverage, provider workflows, and the real operational burden behind reliable billing. ⚙️📉 Inspired by Matt Kamen's excellent post on CPT adoption curves & the recent ACCESS discussion, we’re sharing our internal framework: 𝐐𝐮𝐞𝐬𝐭𝐢𝐨𝐧𝐬 𝐭𝐨 𝐀𝐬𝐤 𝐁𝐞𝐟𝐨𝐫𝐞 𝐁𝐞𝐭𝐭𝐢𝐧𝐠 𝐨𝐧 𝐚 𝐍𝐞𝐰 𝐁𝐢𝐥𝐥𝐢𝐧𝐠 𝐂𝐨𝐝𝐞 It goes deeper than payment policy — covering clinical and documentation requirements, enrollment and service mechanics, operational readiness, and the maturity of the CPT pathway. 🧠📋 If you’re evaluating a CPT-driven business model — or working with someone who is — comment “𝘾𝙋𝙏” below + DM me & I’ll share the document. 📄➡️ #startups #HealthcarePolicy #HealthTech #CMMI #ACCESSModel #Medicare #DigitalHealth
64 Comments -
Ken Nelson
Matt Holt, former New Mountain Capital executive, is exploring a $30 billion deal to combine five health tech startups into a single platform called Thoreau. The venture would set out to simplify and integrate services across payers, providers and data — and if completed, it would rank among the largest private equity-backed health tech companies ever. Time will tell if this massive consolidation ever gets completed or translates into real value — or if it's just another bet on scale.
3 Comments
Explore top content on LinkedIn
Find curated posts and insights for relevant topics all in one place.
View top content